Having in mind the frequent asymptomatic nature of coal worker's pneumoconiosis (CWP) or silicosis, the principal occupational factors in the pathogenesis of Caplan syndrome, patients often present with little or no respiratory symptoms [1] [2]. Mild dyspnea, most notably on exertion, was noted as the principal complaint in recent case reports [1] [2], while a cough and hemoptysis are absent. In fact, the disease is often discovered incidentally, while virtually all patients present with one or more manifestations of rheumatoid arthritis (RA) [2] [3]:

• Polyarthritis, tendinitis, bursitis - Most commonly involving the wrist and hand joints; profound inflammation seen in RA causes polyarthritis accompanied by morning stiffness, usually in a symmetrical fashion.
• Nodules - Firm, nontender nodules that develop most frequently in the forearms, calfs, and the sacrum, are one of the main features of RA, and their subcutaneous appearance may be followed by their development in visceral organs, including the lungs, which is the cardinal feature of Caplan syndrome.
• Constitutional symptoms - Fever, fatigue, malaise and cachexia ensue as a result of extensive inflammatory changes.

Although seen in a very small number of patients, cardiac (ischemic heart disease, cardiomyopathy, pericarditis) and hematologic (anemia, neutropenia, splenomegaly) features may also be encountered in RA patients [3].

Because Caplan syndrome is strongly associated with occupational exposure to coal dust or silica, a detailed patient history with an emphasis on previous occupations may be one of the most important steps during workup. Similarly, assessment of signs and symptoms suggestive of RA (if the diagnosis is not already known) can only be made after a meticulous history taking, but the role of a thorough physical examination is equally important. The diagnosis of Caplan syndrome, however, relies on findings obtained from imaging studies - radiography and computed tomography (CT) of the thorax [4] [5]. Well-defined lung nodules that range from 0.5-5 cm, predominantly located in the periphery, are typical radiographic lesions seen in these patients [1] [4]. Coalescence of nodules and formation of a large confluent nodule, cavitation or calcification may also be observed [4]. On the other hand, confirmation of RA is necessary by performing appropriate laboratory tests, in addition to clinical criteria. Evaluation of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies are mandatory if clinical suspicion toward RA exists. The combination of radiographic findings, occupational risk factors, and laboratory results should be sufficient to make the diagnosis of Caplan syndrome.

Treatment of Caplan Syndrome focuses on managing both rheumatoid arthritis and lung disease. Nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs) are commonly used to control joint inflammation and pain. In some cases, biologic agents may be prescribed. For lung involvement, treatment may include bronchodilators or corticosteroids to alleviate respiratory symptoms. Avoidance of further exposure to coal dust is essential to prevent disease progression.

The prognosis for Caplan Syndrome varies depending on the severity of both the rheumatoid arthritis and the lung disease. With appropriate management, many patients can maintain a good quality of life. However, the presence of lung nodules can complicate the course of the disease, potentially leading to respiratory complications. Regular monitoring and follow-up with healthcare providers are important to manage symptoms and prevent complications.

Caplan Syndrome is caused by the combination of rheumatoid arthritis and exposure to coal dust or other pneumoconiosis-inducing agents. The exact mechanism is not fully understood, but it is believed that the inhalation of coal dust particles triggers an immune response in individuals with a predisposition to rheumatoid arthritis, leading to the formation of lung nodules.

Caplan Syndrome is a rare condition, primarily affecting individuals with a history of occupational exposure to coal dust, such as coal miners. The incidence has decreased over the years due to improved working conditions and reduced exposure to coal dust. It is more common in men, reflecting the demographics of the coal mining workforce.

The pathophysiology of Caplan Syndrome involves an immune-mediated response to inhaled coal dust particles in individuals with rheumatoid arthritis. The dust particles are engulfed by immune cells in the lungs, leading to inflammation and the formation of nodular lesions. These nodules are typically round and well-defined, and they can vary in size.

Preventing Caplan Syndrome involves minimizing exposure to coal dust and other pneumoconiosis-inducing agents. This can be achieved through the use of protective equipment, such as masks and respirators, and by implementing workplace safety measures to reduce dust levels. Regular health screenings for workers in high-risk occupations can also aid in early detection and management.

Caplan Syndrome is a rare condition characterized by the coexistence of rheumatoid arthritis and pneumoconiosis, particularly in individuals exposed to coal dust. It presents with joint and respiratory symptoms, and diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. Treatment focuses on managing both rheumatoid arthritis and lung disease, with a good prognosis achievable with appropriate care. Prevention is centered on reducing exposure to coal dust.

If you have been diagnosed with Caplan Syndrome, it means you have both rheumatoid arthritis and lung nodules due to exposure to coal dust. It's important to work closely with your healthcare provider to manage your symptoms and prevent complications. Treatment may include medications for joint pain and inflammation, as well as therapies to help with breathing. Avoiding further exposure to coal dust is crucial. Regular check-ups and monitoring can help maintain your quality of life.

1. De Capitani EM, Schweller M, Silva CM, Metze K, Cerqueira EM, Bértolo MB. Rheumatoid pneumoconiosis (Caplan's syndrome) with a classical presentation. J Bras Pneumol. 2009;35(9):942-946.
2. Rozenberg D, Shapera S. What to do with all of these lung nodules? Can Respir J. 2014;21(3):e52-e54.
3. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 18e. New York, NY: McGraw-Hill; 2012
4. Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Rheumatoid pneumoconiosis (Caplan's syndrome). Eur J Intern Med. 2010;21(3):168-72.
5. Arakawa H, Honma K, Shida H, Saito Y, Morikubo H. Computed tomography findings of Caplan syndrome. J Comput Assist Tomogr. 2003;27(5):758-760..